Roberto Padoan

Rheumatologist | MD, PhD | #Vasculits and #Raredisease centre @Unipd_Medicina |
@SIRreumatologia member

[Roberto Padoan @roberto_padoan]

🚨New paper out in @FrontImmunol!

We report 24-month real-world prospective data comparing benralizumab and two mepolizumab regimens in #EGPA.

All regimens showed clinical benefit, marked glucocorticoid sparing and safety.

🔗 https://t.co/S6eUGArqzc

#Vasculitis #Padua

[European EGPA Study Group @EgpaGroup]

Thank you to everyone who stopped by the EESG booth at #EULAR2026
👏A special thanks to all our members who contributed with presentations, posters, discussions and great energy.
✨It is wonderful to be part of such a connected and supportive group, growing stronger together.

[Rheumatology Unit - DIMED, University of Padova @UnitPadova]

La Reumatologia dell’Azienda Ospedaliera Università di Padova al Congresso Europeo di Reumatologia a Londra #eular2026

[Roberto Padoan @roberto_padoan]

@DurgaPrasannaM1 Thanks!!!!

[Roberto Padoan @roberto_padoan]

‼️Excited to share our latest publication.

➡️In this review, we discuss how AAV management is moving from broad immunosuppression toward a more precise, mechanism-based approach.

https://t.co/VPUmdsUcXX

[Roberto Padoan @roberto_padoan]

Proud and delighted to be here with my amazing team from the Padua Vasculitis Center at the 22nd International Vasculitis Workshop (IVW) in Melbourne 🇦🇺
Honoured to present several projects and share ideas with the global vasculitis community, lots of inspiration ahead. #IVW26

[ZoiAn @ZoiAn2]

Thank you Dr Roberto Padoan for an excellent presentation at the @anzvasc !
#vasculitis @_ERNRITA

[European EGPA Study Group @EgpaGroup]

✨Grateful for everyone who took part in the 11th EESG Meeting!
Thank you for the inspiring insights and truly productive discussions. It was a pleasure to share ideas, exchange perspectives, and move our work forward together. 🚀

#EESG #Vasculitis26

[Roberto Padoan @roberto_padoan]

@ZoiAn2 @anzvasc @_ERNRITA Thanks a lot!!!

[Roberto Padoan @roberto_padoan]

@DurgaPrasannaM1 Thanks!!!

[Roberto Padoan @roberto_padoan]

✅ New paper out in Inflammation Research: we find signs of subclinical immune activation even during remission in ANCA-associated vasculitis—especially ANCA+ EGPA.

⚠️Potential value for immune monitoring.

https://t.co/wY0MMBA4gi

#EGPA #AAV #Vasculitis

[Roberto Padoan @roberto_padoan]

✅We’re excited to share our new work. Just published in ACR Open Rheumatology (@ACR_Journals)!
Switching to subcutaneous infliximab may simplify Takayasu maintenance while keeping disease control.
Link: https://t.co/HxHOov9lQ4
#RheumTwitter #Rheumatology #Takayasu #Vasculitis

[Roberto Padoan @roberto_padoan]

The program for the 22nd International Vasculitis Workshop has now launched!
Filled with amazing plenary speakers and sessions.

Visit the website https://t.co/kfmDHw7a2o and start planning your Workshop! 
🇦🇺

[Roberto Padoan @roberto_padoan]

@DurgaPrasannaM1 Thanks a lot Durga!

[Roberto Padoan @roberto_padoan]

🚨New paper out in Annals of Medicine: 3-year single-center experience with #benralizumab in #EGPA.

Remission ↑ 39%→65%, steroid use ↓ 91%→15%, eosinophils ��� 0; good 3-yr retention, mostly mild AEs.

Toward true steroid-sparing care. 🔗 https://t.co/w8B6wXel4M #vasculitis

[European EGPA Study Group @EgpaGroup]

✨ A big thank you to everyone for such a wonderful and inspiring day at the 𝟭𝟬𝘁𝗵 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗘𝗚𝗣𝗔 𝗦𝘁𝘂𝗱𝘆 𝗚𝗿𝗼𝘂𝗽 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 hosted in the magnificent setting of the Maison de l’Amérique Latine, Paris🇫🇷
A unique opportunity for exchange and collaboration🤝

[Vasculitis_Lund @Vasculitis_Lund]

New Publication Alert
Thrilled to share our review on relapse in ANCA-associated vasculitis (AAV).
We summarise what’s known about relapse risk & management, highlighting emerging pathogenic & therapeutic paradigms.
Read here: https://t.co/tTZvyzkt60
Big thanks to my co-authors!

[JCM MDPI @JCM_MDPI]

#mdpijcm
#Editor’s Choice Paper🙌
#HighlyReviewed
Cocaine- and Levamisole-Induced #Vasculitis: Defining the Spectrum of #Autoimmune Manifestations
📌https://t.co/Rp7X2uURM5
🏫University of Padua
by Luca Iorio et al. @UnitPadova @FedeDavanzo @roberto_padoan @MediPharma_MDPI

[Rheumatology Unit - DIMED, University of Padova @UnitPadova]

Our Chief prof. Andrea Doria and dr Roberto Padoan at the Rheumatology and Immunology Summit 2025, Dubai, 12-13 Aprile 2025

[Roberto Padoan @roberto_padoan]

Talking about #ANCA associated #vasculitis at #CORA2025 in Venice, March 6-8! 🌍 Join me & save on registration until 12 Feb. Let’s connect & debate in Venice! 🙌 #Rheumatology #Autoimmunity https://t.co/bts6Ioe4Qk